ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,855, issued on Jan. 20, was assigned to CureVac SE (Tubingen, Germany).
"KRAS variant mRNA molecules" was invented by Amit Aggarwal (Indianapolis), Katja Fiedler (Tubingen, Germany), Ulrike Gnad-Vogt (Tubingen, Germany), Regina Heidenreich (Tubingen, Germany), Mythili Koneru (Indianapolis) and Gregory D. Plowman (Indianapolis).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an mRNA molecule encoding at least one KRAS variant peptide. Further, the invention provides a pharmaceutical composition and kit comprising the mRNA molecule. The mRNA molecule, pharmaceutical composition and kit are useful for treating cancer."
The...